Option Care Health Inc header image

Option Care Health Inc

OPCH

Equity

ISIN null / Valor 52359365

NASDAQ (2026-06-05)
USD 20.51+2.19%

Option Care Health Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Option Care Health Inc is the largest national independent provider of infusion therapy in the United States, delivering a comprehensive range of treatment options for patients with chronic and acute medical conditions. The company specializes in administering intravenous medications, including antibiotics, chemotherapy, and other specialized therapies, both in home settings and clinical environments. By partnering with pharmaceutical manufacturers, insurance providers, and healthcare systems, Option Care Health ensures integrated clinical and administrative support, facilitating seamless service delivery. Their extensive network and expertise enable effective patient care, positioning the company as a key player in the infusion therapy sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (17.05.2026):

Option Care Health Inc - first quarter of 2026 results show a mixed performance: modest revenue growth (net revenue $1,350.7M, +1.3% y/y) but softer operating and adjusted profitability, with GAAP net income of $45.3M (down 3.0%) and Adjusted EBITDA of $104.8M (down 6.3%). GAAP diluted EPS was $0.29 (up modestly), adjusted diluted EPS was $0.40 (flat), and the company used $12.1M of cash in operating activities in Q1 2026 while expanding its revolving credit facility and repurchasing $17.5M of stock.

Revenue & operating results

Net revenue for the first quarter of 2026 was $1,350.7M (+1.3% versus Q1 2025). Gross profit was $262.0M (slightly below prior year) and operating income declined to $72.5M from $79.2M in Q1 2025.

GAAP and adjusted profitability

GAAP net income for Q1 2026 was $45.3M (down 3.0% y/y) with GAAP diluted EPS $0.29. Adjusted EBITDA was $104.8M (down 6.3% y/y) and adjusted diluted EPS was $0.40 (flat vs. Q1 2025).

Earnings per share & share count

GAAP diluted EPS rose to $0.29 despite lower net income, driven by a reduced diluted share count (158.2M diluted shares in Q1 2026 vs 166.8M in Q1 2025), reflecting share repurchases ($17.5M during the quarter).

Cash flow & balance sheet

Option Care Health Inc used $12.1M in operating cash in Q1 2026 (worse than $7.2M used in Q1 2025). Cash and cash equivalents ended at $177.3M (down from $232.6M at the beginning of the quarter). Total assets were $3,380.1M and total liabilities were $2,029.0M.

Capital actions & liquidity

The company repurchased $17.5M of stock in the quarter and expanded its revolving credit facility from $400M to $850M, increasing available liquidity.

Updated 2026 guidance

For full year 2026 the company provided guidance of net revenue $5.675B–$5.775B, adjusted diluted EPS $1.82–$1.92, adjusted EBITDA $480M–$505M, and projected cash provided by operating activities of at least $320M.

Management commentary

Management characterized Q1 2026 as a mixed performance and stated they are not satisfied with revenue growth momentum, signaling focus on improving top-line trends going forward.

Summarized from source with an LLMView Source

Key figures

-36.2%1Y
-32.4%3Y
8.69%5Y

Performance

31.8%1Y
36.4%3Y
37.9%5Y

Volatility

Market cap

3221 M

Market cap (USD)

Daily traded volume (Shares)

2,646,479

Daily traded volume (Shares)

1 day high/low

22.85 / 22.49

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.19%USD 486.98
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.66%USD 170.30
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%USD 15.62
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 42.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.08%USD 19.52
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.00%CHF 0.91
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.85%CHF 117.98
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 13.71
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.04
Interparfums Inc
Interparfums Inc Interparfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.69%USD 91.27